Skip to content

Study on the combined prevention and treatment in patients with Myopia and Intermittent Exotropia

Study on the combined prevention and treatment in patients with Myopia and Intermittent Exotropia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100053154
Enrollment
Unknown
Registered
2021-11-13
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intermittent exotropia, myopia

Interventions

IXT with myopia (Surgical treatment group):Surgical treatment group
myopia:Nil
IXT witout myopia:Nil
Healthy control group:Nil

Sponsors

Beijing Tongren Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 15 Years

Inclusion criteria

Inclusion criteria: 1.Aged between3 and 15 years; 2.Best-corrected visual acuity better than or equal to 20/20 in both eyes, binocular vision function 3.Evidence of IXT on the basis of history and clinical examination; 4.Evidence of myopia on the basis of history and clinical examination(<=0.50 D in Spherical Equivalent Refraction) 5.Be able to understand and cooperate with examinations, sign informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1.Anisometropia (>2.50 D In Spherical Equivalent Refraction); 2.Structural ocular pathology; 3.Accompanied by vertical strabismus, DVD; 4.History of diseases of central nervous system and the whole body; 5.Previous eye surgery history.

Design outcomes

Primary

MeasureTime frame
ocular accommodation, convergence and binocular visual function;BOLD-fMRI;

Secondary

MeasureTime frame
identification of amblyopia and strabismus;Newcastle Control Score evaluation;Optometry examination;ocular biometry;

Countries

China

Contacts

Public ContactJing Fu

Beijing Tongren Hospital

fu_jing@126.com+86 13801218591

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026